Predictors of Abstinence and Changes in Psychiatric Symptoms in a Pooled Sample of Smokers with Schizophrenia receiving Combination Pharmacotherapy and Behavioral Therapy for Smoking Cessation

Ítems similars

• Effects of Acute Abstinence, Reinstatement, and Mecamylamine on Biochemical and Behavioral Measures of Cigarette Smoking in Schizophrenia
  per: Weinberger, Andrea H., et al.
  Publicat: (2007)
• Pharmacotherapy for Smoking Cessation in Schizophrenia: A systematic review
  per: Kozak, Karolina, et al.
  Publicat: (2020)
• Prefrontal Cognitive Dysfunction is Associated with Tobacco Dependence Treatment Failure in Smokers with Schizophrenia
  per: Moss, Taryn G., et al.
  Publicat: (2009)
• A Placebo-Controlled Trial of Bupropion Combined with Nicotine Patch for Smoking Cessation in Schizophrenia
  per: George, Tony P., et al.
  Publicat: (2007)
• Changes in smoking expectancies in abstinent, reducing, and non-abstinent participants during a pharmacological trial for smoking cessation
  per: Weinberger, Andrea H., et al.
  Publicat: (2010)